University of Verona
Department of Medicine and Public Health
Section of Psychiatry and Clinical Psychology
WHO Collaborating Centre for Research and Training in Mental Health
and Service Evaluation
Head: Professor Michele Tansella
The WHO Collaborating Centre in Verona is located in a recently refurbished building, within the University General
Hospital of Verona (Policlinico G.B. Rossi, Piazzale L.A. Scuro 10, 37134 Verona, Italy). It was designated by WHO
as Collaborating Centre for Research and Training in Mental Health on 23 February 1987. According to WHO
regulations the designation lasts for four years and may be continued, with periodic reviews by WHO of the scientific
performance of the Centre. The designation was confirmed in 1992. In September 1996 the Centre was re-designated as
a WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation and since then
this designation was further confirmed in 2001 and 2005.
The main research activities, carried out by the five Research Units of the Centre, focus on epidemiological and social
psychiatry (including economics and geography of mental health studies), genetics and neuroimaging of schizophrenic
and bipolar disorders, clinical psychopharmacology, communication in medicine and evaluation of mental health
services. The staff (more than 50 persons) includes psychiatrists, clinical psychologists, computer scientists, physicists,
geographers and social scientists, statisticians, technicians and secretaries.
Research Units
Psychiatric Register, Economics and Geography of Mental Health
Head: Professor Francesco Amaddeo, MD, PhD
Clinical Psychopharmacology & Drug Epidemiology
Head: Dr. Corrado Barbui, MD
Brain Imaging & Neuropsychology
Head: Dr. Paolo Brambilla, MD, PhD
Environmental, Clinical and Genetic Determinants of Outcome of Mental Disorders
Head: Professor Mirella Ruggeri, MD, PhD
Clinical Psychology & Communication in Medicine
Head: Professor Christa Zimmermann, Dr.Pychol., PhD
Total Impact Factor (I.F.) of Papers Published by Members of the WHO Centre of Verona
2002:
2003:
2004:
I.F. 50.999
I.F. 62.072
I.F. 83.134
2005:
I.F. 116.637
2006:
I.F. 76.469
2007:
I.F. 224.870
In press: I.F. 101.940
Papers Published in 2007 in International Peer Reviewed Journals.
List of Journals and Impact Factor 2007
Pag. 3
Main On-Going Research Projects 2007
Pag. 4
Complete References of Full Papers and Books Published in 2007
Pag. 7
For further information and for receiving copies of papers included in this list, please contact our Librarian:
Dr. Renato Fianco
Tel. +39 045 812 6415 [email protected]
Versione 30 03.10.08
2
Papers Published in 2007 in International Peer Reviewed journals. List of Journals
and Impact Factor (2007)
International Journals
Acta Psychiatrica Scandinavica
American Journal of Medical Genetics Part B- Neuropsychiatric
Genetics
Archives of General Psychiatry
Archives of Women's Mental Health
BMC Psychiatry
BMJ Clinical Evidence
British Journal of Psychiatry
British Medical Journal
Canadian Journal of Psychiatry
Cochrane Database of Systematic Reviews
Epidemiologia e Psichiatria Sociale
European Archives of Psychiatry and Clinical Neuroscience
European Journal of Clinical Pharmacology
Evidence Based Mental Health
Human Psychopharmacology
International Clinical Psychopharmacology
International Review of Psychiatry
Journal of Anatomy
Journal of Clinical Psychopharmacology
Journal of Mental Health
Journal of Nervous and Mental Disease
Journal of Psychiatric Research
Lancet
Patient Education and Counseling
Pharmacoepidemiology and Drug Safety
Psychiatry Research – Neuroimaging
Psychological Bulletin
Psychological Medicine
Psychopathology
Psychopharmacology
Schizophrenia Research
Social Science & Medicine
Zeitschrift für ärztliche Fortbildung und Qualität im
Gesundheitswesen
TOTAL
Number Impact
of papers Factor
Total
9
3.782
34.038
1
4.224
4.224
1
1
1
2
3
1
4
8
14
2
1
5
1
1
2
1
1
1
1
1
1
1
1
1
1
2
1
1
1
1
15.976
1.912
5.446
9.723
3.026
4.654
2.900
2.809
2.177
3.262
1.762
2.547
3.878
1.957
3.710
28.638
1.792
2.475
2.275
10.905
4.212
1.441
3.561
4.240
2.453
1.597 (10%)
1.912
16.338
9.723
12.104
37.232
37.700
5.618
2.177
3.262
3.524
2.547
3.878
1.957
3.710
2.863 (10%)
1.792
2.475
2.275
10.905
8.424
1.441
3.561
4.240
2.453
1
-
-
74
224.870
3
Main On-Going Research Projects 2007, by Research Units
Psychiatric Register, Economics and Geograpy of Mental Health
Head: Professor Francesco Amaddeo. MD, PhD
Mortality and avoidable mortality among psychiatric patients. A 20-year case register study
(G. Perini, A. Biggeri, L. Grigoletti, A. Rossi, C. Barbui, M. Tansella & F. Amaddeo)
Mortality for cancer in Verona in psychiatric patients and in the general population
(M. Tansella, F. Amaddeo, C. Barbui, G. Perini, L. Grigoletti, M. Nosè & A. Rossi)
Geographical distance, socio-economic status (SES) and utilization of community-based mental health services
(L. Grigoletti, J. Jones, G. Zulian, M. Mazzi, V. Donisi, M. Ballarin, M. Tansella & F. Amaddeo)
Urbanicity and psychiatric care
(G. Zulian, V. Donisi, L. Grigoletti, A. Rossi, E. Rigon, M. Tansella & F. Amaddeo)
Mobility of psychiatric patients in community-based mental health centres
(G. Zulian, V. Donisi, L. Grigoletti, L. Rabbi & F. Amaddeo)
Continuity of care and outcome in a community-based system of mental health care
(A. Rossi, V. Vailati Venturi & F. Amaddeo)
The evaluation of a new funding system for mental health departments: results from a multi-centre Italian study (Ipsycost)
(L. Grigoletti, A. Grassi, M. Boldrini, M. Chiappelli, M. Percudani, F. Catapano, A. Fiorillo, L. Bartoli, M. Bacigalupi,
P. Albanese, S. Simonetti, F. Perali, P. De Agostini, M. Tansella & F. Amaddeo)
Economic evaluation of psychiatric care in Ukraina, Moldova and Georgia
(F. Amaddeo)
Clinical Psychopharmacology & Drug Epidemiology
Head: Dr. Corrado Barbui, MD
Monitoring the use of psychotropic drugs in clinical practice: analysis of a psychotropic drug register
(M. Nosè, A. Veronese, E. Esposito, M Bianchini, P. Petrosemolo & C. Barbui)
Selective serotonin-reuptake inhibitors versus other types of pharmacotherapy for depression: systematic reviews and
meta-analyses of randomised controlled trials.
(A. Cipriani, A Signoretti, M. Dieterich, S Mulè & C. Barbui)
Comparative efficacy and acceptability of 12 new generation antidepressants: a mixed-treatment comparison metaanalysis.
(A. Cipriani, T. A. Furukawa, G. Salanti, J.R. Geddes, R. Churchill, J. Higgins, H. McGuire, N. Watanabe, A.
Signoretti, A. Nakagawa, M. Nosè, I.M. Omori, A. Veronese & C. Barbui)
Clozapine, Haloperidol, Aripiprazole Trial (CHAT): Randomized evaluation of the effectiveness of clozapine and
aripiprazole versus clozapine and haloperidol in the treatment of schizophrenia. An independent, pragmatic,
multicentre, parallel-group, superiority trial.
(C. Barbui, A. Cipriani, M. Nosè, A. Veronese, E. Esposito, A. Cicolini, S. Mulè, P. Petrosemolo, S. Accordini & M.
Tansella)
Brain Imaging & Neuropsychology
Head: Dr. Paolo Brambilla, MD, PhD
Brain connectivity and neuroimmunology in schizophrenia and bipolar disorders
(M. Bellani, A. Ferro, M. Atzori, C.A. Marzi, S. Savazzi, A. Beltramello, M. Tansella & P. Brambilla)
The neurobiological underpinnings of social psychiatry.
(N. Dusi, G. Rambaldelli, C. Perlini, S. Sponda, R. Cerini, R. Pozzi-Mucelli, M. Tansella & P. Brambilla)
Cortical gray and white matter segmentation of human brain
(M. Atzori, A. Beltramello, M. Tansella & P. Brambilla)
4
Brain shape morphometry in healthy humans and patients with major psychoses
(G. Rambaldelli, U. Castellani, V. Murino, & P. Brambilla)
Investigation of executive functions in schizophrenia and bipolar disorders
(S. Sponda, S. Cerruti, S. Frangou, M. Tansella & P. Brambilla)
Speech and language disturbances in schizophrenia
(C. Perlini, F. Fabbro, A. Tavano, S. Sponda, M. Tansella & P. Brambilla)
Perfusion imaging studies in human brain
(D. Peruzzo, M. Atzori, A. Bertoldo, F. Zanderigo, M. Tansella, C. Cobelli, & P. Brambilla)
Environmental, Clinical and Genetic Determinants of Outcome of Mental Disorders
Head: Professor Mirella Ruggeri, MD, PhD
Sgene: A Large Scale Genome-Wide Association Study Of Schizophrenia Addressing Variation In Expressivity And
Contribution From Environmental Factors
(S. Tosato, C. Bonetto, M. Ruggeri)
Toward A New Definition Of Schizophrenia: The Biological Basis Of A Core Phenotype – Joint Project
Glaxo/University of Verona
(S. Tosato, C. Bonetto, M. Bertani, A. Lasalvia, M. Ruggeri)
Individuazione e trattamento della Depressione in comorbilità con malattie fisiche in collaborazione con le Unità
operative dell’Ospedale Generale (Reparti/Day-Hospital e Ambulatori)
(M. Ruggeri, K. De Santi, D. Cappellari, A. Cipriani, C. Barbui)
PICOS- Psychosis Incident Cohort Outcome Study. A multisite collaborative project on the clinical, social and
biological factors predicting outcome in the new cases of psychoses in the Veneto Region, Italy
(M. Ruggeri, A. Lasalvia, M. Bertani, C. Bonetto, S. Bissoli, G. Marrella, S. Tosato, P. Brambilla, M. Tansella &
Gruppo PICOS)
Genotype, endophenotype and phenotype: identifying etiopathogenetic factors of psychoses for the development of
preventive models and individualised therapeutic strategies
(M. Ruggeri, S. Tosato, R. Mazzoncini, A. Lasalvia, C. Bonetto, D. Collier, M. Di Forti, R. Murray & M. Tansella)
Outcome evaluation of sheltered hostels for mentally disabled people in 17 Italian Regions.
(M. Ruggeri. A. Lasalvia, R. Radici, S. Zizolfi & G.Fioretti)
Schizotaxia: epidemiology and clinical and neuropsychological validation
(M. Ruggeri, A. Lasalvia, S. Scala, G. Marrella, M. Tansella, C. Bonetto, D..Berardi, G.F. Placidi & S. Scarone)
South-Verona Outcome Project: follow-up evaluation of prevalence cohorts of patients attending the South-Verona
Community Mental Health Service.
(M. Ruggeri, A. Lasalvia, C. Bonetto, D. Cristofalo & M. Tansella)
Relationship between the presence of candidate gene (Dysbindine, Neureguline 1, BDNF) for schizophrenia and illness
onset and severity: a 5-year follow-up study
(M. Ruggeri, S. Tosato, C. Bonetto, A. Lasalvia, D. Collier, M. Di Forti, R. Murray & M. Tansella)
Implementing mental health promotion action (IMHPA Study)
(M. Ruggeri, M. Stegagno & M. Bertani)
Implementing NICE Guidelines of schizophrenia in routine clinical practice: a multisite project in Italian mental health
services
(L. Burti, A. Lasalvia, S. Bissoli, D. Semisa & M. Ruggeri)
Group treatment of panic disorder. A controlled trial
(M. Ruggeri, C. Bonetto, D. Cappellari, A. Cipriani, D. Cristofalo, R. Dall’Agnola, C. Goss, M. Rimondini, S. Tosato &
C. Zimmermann)
International Study of Discrimination and Stigma Outcomes (INDIGO Multisite Study)
(A.Lasalvia, D. Maggiolo, A. Ricci, A. Cicolini & M. Tansella)
5
Assessing self-percieved discrimination and stigma following the first episode of psychosis by using the DISC-11 Scale
(A.Lasalvia, G. Thornicroft, M. Bertani, N. Pellegrini, G. Marrella, S. Bissoli, L. Lazzarotto & M. Ruggeri)
Clinical Psychology & Communication in Medicine
Head: Professor Christa Zimmermann, Dr. Psychol., PhD.
Information giving in psychiatric and general hospital patients
(C. Goss, L. Del Piccolo, M.A. Mazzi, S. Fontanesi. F. Moretti, M. Rimondini & Ch. Zimmermann)
The involvement of psychiatric patients in the decision making process
(Ch. Zimmermann, L. Del Piccolo, C. Goss, T. Pozzan, M.A. Mazzi & M. Rimondini)
The evaluation of communication skills training in psychiatry.
(M. Rimondini, L. Del Piccolo, C. Goss, M.A. Mazzi & Ch. Zimmermann)
Validation of the consensus definitions of patient cues/ concerns and related physician behaviour during medical
consultations.
(L. Del Piccolo, C. Goss, M.A. Mazzi, F. Moretti, M. Rimondini & Ch. Zimmermann)
Citizens’ view and preferences concerning communication issues in medicine . A multicentre study
(F. Moretti , Jozien Bensing, Ian Fletcher, M. Rimondini, M.A. Mazzi, L. Del Piccolo, C. Goss,, & Ch. Zimmermann)
6
Complete References of Full Papers and Books Published in 2007
This list includes full papers, chapters of books and monographs and volumes published or accepted for
publication in 2007. The latest Impact Factor (I.F.) scores (2007) are indicated.
The list includes also Letters, but only those peer-reviewed and published in outstanding Journals.
According to the rules of the Scientific Committee of the Medical School of the University of Verona these
Letters are given an I.F. score that is 10% of the original score.
Abstracts of papers presented at scientific Meetings and Congresses and posters are NOT included.
A) PAPERS PUBLISHED IN INTERNATIONAL JOURNALS
Abhijnhan A., Cipriani A. & Barbui C. (2007). Clotiapine for schizophrenia (Protocol). Cochrane Database of
Systematic Reviews Issue 2.
I.F. 2007: 4.654
Amaddeo F. & Jones J. (2007). What is the impact of socio-economic inequalities on the use of mental health services?
Epidemiologia e Psichiatria Sociale 16, 16-19.
I.F. 2007: 2.900
Amaddeo F. & Tansella M. (2007) Economics of mental health. New challenges and perspectives. Epidemiologia e
Psichiatria Sociale 16, 279-281.
I.F. 2007: 2.900
Amaddeo F., Barbui C., Perini G., Biggeri A. & Tansella M. (2007). Avoidable mortality of psychiatric patients in an
area with community-based system of mental health care. Acta Psychiatrica Scandinavica 115, 320-325.
I.F. 2007: 3.782
Amaddeo F., Grigoletti L., de Girolamo G., Picardi A., Santone G. & the PROGRES Study Group (2007). Which
factors affect the costs of residential psychiatric care? Findings from the Italian PROGRES study. Acta
Psychiatrica Scandinavica 115, 132-141.
I.F. 2007: 3.782
Andreone N., Tansella M., Cerini R., Rambaldelli G., Versace A., Marrella G., Perlini C., Dusi N., Polizza L.,
Balestrieri M., Barbui C., Nosè M., Gasparini A. & Brambilla P. (2007). Cerebral atrophy and cortical white
matter disruption in chronic schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 257, 311.
I.F. 2007: 2.809
Andreone N., Tansella M., Cerini R., Versace A., Rambaldelli G., Marrella G., Perlini C., Dusi M., Pelizza L., Barbui
C., Nosè M., Gasparini A. & Brambilla P. (2007). Cortical white matter disruption in schizophrenia: a
diffusion imaging study. British Journal of Psychiatry 191, 113-119.
I.F. 2007: 5.446
Baiano M., David A., Versace A., Churchill R., Balestrieri M., Brambilla P. (2007). Anterior cingulate volumes in
schizophrenia: A systematic review and a meta-analysis of MRI studies. Schizophrenia Research 93, 1-12.
I.F. 2007: 4.240
Balestrieri M., Baldacci S., Bellantuono C., Conti L., Perugi G., Nardini M., Borbotti M. & Viegi G. (2007). Clinical vs.
structured interview on anxiety and affective disorders by primary care physicians. Understanding diagnostic
discordance. Epidemiologia e Psichiatria Sociale 16, 144-151.
I.F. 2007: 2.900
Barbui C. & Cipriani A. (2007). Evidence based psychopharmacology: a public health agenda for the future. Evidence
Based Mental Health 10, 4-6.
Barbui C. & Cipriani A. (2007). Publication bias in systematic reviews. Archives of General Psychiatry 64, 868.
I.F. 2007: 15.976 (10%= 1.597)
Barbui C. & Garattini S. (2007). Regulatory policies on medicines for psychiatric disorders: is Europe on target? British
Journal of Psychiatry 190, 91-93.
I.F. 2007: 5.446
Barbui C. & Tansella M. (2007). Academic psychiatry and the pharmaceutical industry: useful partnership or dangerous
interaction? Epidemiologia e Psichiatria Sociale 16, 189-191.
I.F. 2007: 2.900
Barbui C., Mulè S. & Cipriani A. (2007). Commentary: Haloperidol, risperidone and olanzapine are similarly effective
for first-episode non-affective psychosis but have differing side effects. Evidence Based Mental Health 10, 74.
7
Barbui C., Veronese A. & Cipriani A. (2007). Explanatory and pragmatic trials. Epidemiologia e Psichiatria Sociale 16,
124-125.
I.F. 2007: 2.900
Barbui C., Biancosino B., Esposito E., Marmai L., Donà S. & Grassi L. (2007). Factors associated with antipsychotic
dosing in psychiatric inpatients: a prospective study. International Clinical Psychopharmacology 22, 221-225.
I.F. 2007: 3.262
Barbui C., Butler R., Cipriani A., Geddes J.R. & Hatcher S. (2007). Depression in adults (drug and other physical
treatments). BMJ Clinical Evidence 06, 1-28.
Barbui C., Cipriani A., Lintas C., Bertelè V. & Garattini S. (2007). CNS drugs approved by the centralised European
procedure: true innovation or dangerous stagnation? Psychopharmacology 190, 265-268.
I.F. 2007: 3.561
Bellantuono C., Migliarese G. & Gentile S. (2007). Serotonin reuptake inhibitors in pregnancy and the risk of major
malformations: a systematic review. Human Psychopharmacology 22, 122-128.
Bellantuono C., Barraco A., Rossi A., Goetz I. & Italian EMBLEM study group (2007). The management of bipolar
mania: A national survey of baseline data from the EMBLEM study in Italy. BMC Psychiatry [7], 33.
Biancosino B., Barbui C., Marmai L., Fagioli F., Sabatelli C. & Grassi L. (2007). Relationship between self-reported
and observer-reported ratings for psychopathology in psychiatric inpatients. Psychopathology 40, 418-423.
I.F. 2007: 1.441
Boso M., Cipriani A. & Barbui C. (2007). Clozapine combined with different antipsychotic drugs for treatment resistant
I.F. 2007: 4.654
schizophrenia. (Protocol). Cochrane Database of Systematic Reviews. Issue 1.
Brambilla P. & Tansella M. (2007). Can neuroimaging studies help us in understanding the biological causes of
I.F. 2007: 1.762
schizophrenia? International Review of Psychiatry 19, 313-314.
Brambilla P. & Tansella M. (2007). The role of white matter for the pathophysiology of schizophrenia. International
Review of Psychiatry 19, 459-468.
I.F. 2007: 1.762
Brambilla P., Cerini R., Fabene P.F., Andreone N., Rambaldelli G., Farace P., Versace A., Pelizza L., Gasparini A.,
Gatti R., Barbui C., Nosè M., Tournikioti K., Sbarbati A. & Tansella M. (2007). Assessment of cerebral blood
volume in schizophrenia: a magnetic resonance imaging study. Journal of Psychiatric Research 41, 502-510.
I.F. 2007: 3.710
Chiappelli M., Grigoletti L., Albanese P., Taras M.A.T.P., Grassi A. & Gruppo I-psycost (2007). The cost and
utilization of psychotherapy in Community-based Mental Health Services. A multicentre study in five Italian
areas (in Italian). Epidemiologia e Psichiatria Sociale 16, 152-162.
I.F. 2007: 2.900
Cipriani A. & Barbui C. (2007). Review: antidepressant plus antipsychotic increases clinical response rates in psychotic
depression (Commentary). Evidence Based Mental Health 10, 10.
Cipriani A. & Barbui C. (2007). What is an individual patient data meta-analysis? Epidemiologia e Psichiatria Sociale
16, 203-204.
I.F. 2007: 2.900
Cipriani A. & Barbui C. (2007). Pharmacological treatment for unipolar psychotic depression. Evidence Based Mental
Health 10, 10.
Cipriani A., Barbui C. & Geddes J.R. (2007). Is the onset of action of antidepressants truly delayed? BMJ Clinical
Evidence. Retrieved on http://www.clinicalevidence.com/ceweb/about/editors-letter-full.jsp
Cipriani A., Furukawa T., Churchill R. & Barbui C. (2007). Validity of indirect comparisons in meta-analyses. Lancet
369, 270-271 [Letter]
I.F. 2007: 28.638 (10%=2.863)
Cipriani A., Furukawa T., Veronese A., Watanabe N., Churchill R., McGuire H., Barbui C. & Meta-Analysis of New
Generation Antidepressants (MANGA) Study Group (2007). Paroxetine versus other anti-depressive agents for
depression (Protocol). Cochrane Database of Systematic Reviews Issue 2.
I.F. 2007: 4.654
Cipriani A., Geddes J.R., Furukawa T. & Barbui C. (2007). Meta-review on short-term effectiveness and safety of
antidepressants for depression: An evidence-based approach to inform clinical practice. Canadian Journal of
I.F. 2007: 3.026
Psychiatry 52, 553-562.
8
Cipriani A., Geddes J.R. & Barbui C. (2007). Venlafaxine for major depression: more evidence that risks outweigh
benefits for most patients? British Medical Journal 334, 215-216.
I.F. 2007: 9.723
Cipriani A., Malvini L., Furukawa T. & Barbui C. (2007). Relationship between quality of reports of antidepressant
randomized controlled trials and treatment estimates: systematic review, meta-analysis, and meta-regression
analysis. Journal of Clinical Psychopharmacology 27, 352-356.
I.F. 2007: 3.878
Cipriani A., Nosè M. & Barbui C. (2007). What is a risk ratio? Epidemiologia e Psichiatria Sociale 16, 20-21.
I.F. 2007: 2.900
Cipriani A., Signoretti A. & Barbui C. (2007). Commentary: Antipsychotic plus mood stabiliser co-therapy is more
effective than mood stabiliser mono-therapy at reducing acute bipolar mania. Evidence Based Mental Health 10,
83.
de Girolamo G., Bassi M., Neri C., Ruggeri M., Santone G. & Picardi A. (2007). The current State of mental health
care in Italy: problems, perspectives and lessons to learn. European Archives of Psychiatry and Clinical
Neuroscience 257, 71-82.
I.F. 2007: 2.809
Del Piccolo L., Mazzi M.A., Sandri M., Dunn G. & Zimmermann C. (2007). Sequence analysis in multilevel models. A
study on different sources of patient cues in medical consultations. Social Science & Medicine 65, 2357-2370.
I.F. 2007: 2.453
Esposito E., Wang J.L., Adair C., Williams J.V.A., Dobson K., Schopflocher D., Sevcik M., Mitton C., Newman S.,
Beck C., Barbui C. & Patten S.B. (2007) Frequency and adequacy of depression treatment in Alberta, Canada.
Canadian Journal of Psychiatry, 52, 780-789.
I.F. 2007: 3.026
Fabene P.F., Farace P., Brambilla P., Andreone N., Cerini R., Pelizza L., Versace A., Birbaumer N., Tansella M. &
Sbarbati A. (2007). Three-dimensional perfusion maps: a step beyond volumetric analysis in mental disorders.
Journal of Anatomy 210, 122-128.
I.F. 2007: 2.547
Furukawa T., Cipriani A., Barbui C. & Geddes J.R. (2007). Long-term treatment of depression with antidepressants: A
systematic narrative review. Canadian Journal of Psychiatry 52, 545-552.
I.F. 2007: 3.026
Gava I., Aguglia E., Barbui C., Carlino D., Churchill R., De Vanna M. & McGuire H. (2007). Psychological treatments
versus treatment as usual for obsessive compulsive disorder (OCD). [Reviewl]. Cochrane Database of
I.F. 2007: 4.654
Systematic Reviews Issue 2.
Geddes J.R., Cipriani A., Furukawa T. & Barbui C. (2007). Depressive Disorder needs an evidence base commensurate
with its public health importance. Canadian Journal of Psychiatry 52, 543-544.
I.F. 2007: 3.026
Gentile S., Rossi A. & Bellantuono C. (2007). SSRIs during breastfeeding: spotlight on milk-to-plasma ratio. Archives
I.F. 2007: 1.912
of Women's Mental Health 10, 39-51.
Goss C. & Renzi C. (2007). Patient and citizen participation in health care decisions in Italy. Zeitschrift für ärztliche
Fortbildung und Qualität im Gesundheitswesen 101, 236-240.
Goss C., Fontanesi S., Mazzi M.A., Del Piccolo L., Rimondini M., Elwin G & Zimmermann C. (2007). Shared decision
making: the reliability of the OPTION scale in Italy. Patient Education and Counseling 66, 296-302.
I.F. 2007: 1.792
Goss C., Fontanesi S., Mazzi M.A., Del Piccolo L. & Rimondini M. (2007). The assessment of patient involvement
across consultation. The Italian version of the OPTION scale (in Italian). Epidemiologia e Psichiatria
Sociale,16, 339-349.
I.F. 2007: 2.900
Guaiana G, Barbui C, Churchill R, Cipriani A, McGuire H. (2007). Hydroxyzine for generalised anxiety disorder
(Protocol). Cochrane Datebase of Systematic Reviews. Issue 4.
I.F. 2007: 4.654
Imperadore G., Cipriani A., Signoretti A., Furukawa T., Watanabe N., Churchill R., McGuire H., Barbui C. & MetaAnalysis of New Generation Antidepressants (MANGA) Study Group (2007). Citalopram versus other antidepressive agents for depression (Protocol). Cochrane Database of Systematic Reviews Issue 2.
I.F. 2007: 4.654
Jones J., Amaddeo F., Barbui C. & Tansella M. (2007). Predicting costs of mental health care: a critical literature
I.F. 2007: 4.212
review. Psychological Medicine 37, 467-477.
9
Kikkert M., Barbui C., Koeter M., Schene A., David A., Giessler P., Puschner B., Tansella M. & Gray R. Measures of
Medication Adherence in Patients with Schizophrenia. Journal of Nervous and Mental Disease , 196, 274-281.
I.F. 2007: 1.957
Knapp M., McDaid D., Amaddeo F., Constantopoulos A., Oliveira M.D., Salvador Carulla L., Zechmeister I. & The
MHEEN Group. (2007). Financing mental health care in Europe. Journal of Mental Health 16, 167-180.
Lasalvia A. & Ruggeri M. (2007). Assessing the outcome of community-based psychiatric care: building a feedback
loop from real world health services research into clinical practice. Acta Psychiatrica Scandinavica.
Supplementum 116, No. 437, 6-15.
I.F. 2007: 3.782
Lasalvia A., Gentile B., Ruggeri M., Marcolin A., Nosè F., Cappellari L., Lamonaca D., Toniolo E., Buana C.,
Campedelli A., Cuccato G. C., Danieli A., De Nardi F., De Nardo V., Destro E., Favaretto G., Frazzingaro S.,
Giacopuzzi M., Pristinger P., Pallia P., Rodighiero S., Tito P., Aprile F., Nicolaou S., Coppola G., Garzotto N.,
Gottardi U., Lazzarin E., Migliorini G., Pavan L., Ramaciotti F., Roveroni P., Russo S., Urbani P. & Tansella M.
per il Gruppo PICOS-VENETO. (2007). Eterogeneità dei DSM veneti a dieci anni dal Progetto Obiettivo “Tutela
Salute Mentale 1994-96”. Quali implicazioni per la pratica clinica? Epidemiologia e Psichiatria Sociale 16, 5970.
I.F. 2007: 2.900
Lasalvia A, Bonetto C, Cristofalo D, Tansella M. & Ruggeri M. (2007). Predicting clinical and social outcome of
patients attending “real world” mental health services: a 6-year multi-wave follow-up. Acta Psichiatrica
Scandinavica Supplement 116, No.437, 16-30.
I.F. 2007: 3.782
Lasalvia A., Bonetto C., Salvi G., Bissoli S., Tansella M. & Ruggeri M. (2007). Predictors of changes in needs for care
in patients receiving community psychiatric treatment. A 4-year follow-up study Acta Psychiatrica Scandinavica
Suppl. 116, Issue s437, 31-41.
I.F. 2007: 3.782
Lasalvia A., Bonetto C., Tansella M., Stefani B. & Ruggeri M. (2007). Does staff-patient agreement on needs for care
predict a better mental health outcome? A 4-year follow-up in a community service. Psychological Medicine 38,
I.F. 2007: 4.212
123-133.
Lewison G., Thornicroft G, Szmukler G. & Tansella M. (2007). The fair assessment of the merits of psychiatric
research. British Journal of Psychiatry 190, 314-318.
I.F. 2007: 5.446
Nakagawa A., Watanabe N., Cipriani A., Barbui C., McGuire H., Churchill R., Furukawa T. & Meta-Analysis of New
Generation Antidepressants (MANGA) Study Group (2007). Milnacipran versus other anti-depressive agents for
depression (Protocol). Cochrane Database of Systematic Reviews Issue 2.
I.F. 2007: 4.654
Nosè M., Cipriani A., Furukawa T., Omori I., Churchill R., McGuire H., Barbui C. & Meta-Analysis of New
Generation Antidepressants (MANGA) Study Group (2007). Duloxetine versus other anti-depressive agents for
depression (Protocol). Cochrane Database of Systematic Reviews Issue 2.
I.F. 2007: 4.654
Parabiaghi A., Lasalvia A., Bonetto C., Cristofalo D., Marrella G., Tansella M. & Ruggeri M. (2007). Predictors of
changes in caregiving burden in people with schizophrenia: a 3-year follow-up study in a community mental
health service. Acta Psychiatrica Scandinavica Suppl. 116, No. 437, 66-76.
I.F. 2007: 3.782
Pellegrini N. & Ruggeri M. (2007). La diffusione e le motivazioni dell'
uso delle medicine alternative e complementari
tra gli utenti dei servizi di salute mentale: una revisione sistematica della letteratura. Epidemiologia e Psichiatria
Sociale 16, 35-49.
I.F. 2007: 2.900
Ruggeri M. (2007). Quality of Life, Enjoyment and Satisfaction Questionnaire (Q-Les-Q). Presentazione.
Epidemiologia e Psichiatria Sociale 16, 79-81.
I.F. 2007: 2.900
Ruggeri M. & Tansella M. (2007). Achieving a better knowledge on the causes and early course pf psychoses: a
profitable investment for the future? Epidemiologia e Psichiatria Sociale 16, 97-101.
I.F. 2007: 2.900
Ruggeri M., Lasalvia A., Salvi G., Cristofalo D., Bonetto C. & Tansella M. (2007). Applications and usefulness of
routine measurements of patients satisfaction with community-based mental health care. Acta Psychiatrica
Scandinavica Suppl. 116, No. 437, 53-65.
I.F. 2007: 3.782
Ruggeri M., Salvi G., Bonetto C., Lasalvia A., Allevi L., Parabiaghi A., Bertani M. & Tansella M. (2007). Outcome of
patients dropping out from community-based mental health care: a 6-year multiwave follow-up study. Acta
I.F. 2007: 3.782
Psychiatrica Scandinavica. Supplementum 116, No. 437, 42-52.
10
Tansella M. (2007). Does socio-economic status influence the use of mental health services? Epidemiologia e
Psichiatria Sociale 16, 1-2.
I.F. 2007: 2.900
Tansella M. (2007). The long journey of monitoring and evaluating a new mental health service. Acta Psychiatrica
Scandinavica. Supplementum 116, No. 437, 3-5.
I.F. 2007: 3.782
Tosato S., Ruggeri M., Bonetto C., Bertani M.E., Marrella G., Lasalvia A. Tansella M., Murray R.M. & Collier D.A.
(2007). Association of dysbindin gene with clinical and functioning outcome measures in a representative
cohort of Italian schizophrenic patients. American Journal of Medical Genetics Part B- Neuropsychiatric
I.F. 2007: 4.224
Genetics 144B, 647-659.
Tournikioti K., Tansella M., Cerini R., Versace A., Andreone N., Rambaldelli G., Dusi N., Pelizza L., Barbui., Nosè
M., Gasparini A., Perlini C. & Brambilla P. (2007). Normal pituitary volumes in chronic schizophrenia.
Psychiatry Research - Neuroimaging 154, 41-48.
I.F. 2007: 2.275
Trifirò G., Barbui C., Spina E., Moretti S., Tari M., Alacqua M., Caputi A.C., UVEC Group & Arcoraci V. (2007).
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the
years 2003-2004. Pharmacoepidemiology and Drug Safety 16, 552-559.
I.F. 2007: 2.475
Veronese A., Garatti M., Cipriani A. & Barbui C. (2007). Benzodiazepine use in the real world of psychiatric practice:
low-dose, long-term drug taking and low rates of treatment discontinuation. European Journal of Clinical
I.F. 2007: 2.177
Pharmacology 62, 867-873.
Zimmermann C., Del Piccolo L. & Finset A. (2007). Cues and concerns by patients in medical consultations. A
literature review. Psychological Bulletin 133, 438-463.
I.F. 2007: 10.905
in press
Agarwal N., Bellani M., Perlini C., Rambaldelli G., Attori M., Cerini R., Vecchiato F., Pozzi Mucelli R., Andreone N.,
Balestrieri M., Tansella M. & Brambilla P. Increased fronto-temporal perfusion in bipolar disorder. Journal of
Affective Disorders, in press.
I.F. 2007: 3.144
Agarwal N., Rambaldelli G., Perlini C., Dusi N., Kitis O., Bellani M., Cerini R., Versace A., Balestrieri M., Gasparini
A., Pozzi Macelli R., Tansella M. & Brambilla P. Microstructural thalamic changes in schizophrenia.: A
combined anatomical and diffusion weighted MRI study. Journal of Psychiatry & Neuroscience, in press.
I.F. 2007: 3.662
Baiano M., Perlini C., Rambaldelli G., Cerini R., Dusi N., Bellani M., Spezzapria G., Versace A., Balestrieri M., Pozzi
Mucelli R., Tansella M. & Brambilla P. (2008) Decreased entorhinal cortex volumes in schizophrenia.
Schizophrenia Research, 102, 171-180.
I.F. 2007: 4.240
Barbui C. Commentary on: Rapid tranquillisation in psychiatric emergency settings in Brazil : pragmatic randomised
controlled trial og intramuscular haloperidol versus intramuscular haloperidol plus promethazine. Evidence
Based Mental Health, in press
Barbui C, Furukawa T.A., Cipriani A. (2008). Effectiveness of selective serotonin reuptake inhibitors [Letter].
Canadian Medical Association Journal, 178, 1185-1186.
I.F. 2007: 7.067
Barbui C. & Cipriani A. Commentary: Cognitive improvement after treatment with second-generation antipsychotic
medications in first-episode schizophrenia - Is it a practice effect? Evidence Based Mental Health, in press.
Barbui C., Cipriani A. & Geddes J. Antidepressants and suicide symptoms: compelling new insights from the FDA’s
analysis of individual patient level data. Evidence Based Mental Health, in press.
Barbui C., Furukawa T.A. & Cipriani A. Effectiveness of paroxetine in the acute treatment of adults with major
depression: a systematic re-examination of published and unpublished randomised data. Canadian Medical
Association Journal, in press.
I.F. 2007: 7.067
Barbui C. & Tansella M. (2008) The attitude of patients towards pharmacological and non-pharmacological treatments
in psychiatry: implications for clinical practice, service organisation and research. Epidemiologia e
I.F. 2007: 2.900
Psichiatria Sociale, in press.
Bellani M, Brambilla P. (2008). Is there a neurobiological basis of insight in schizophrenia? Epidemiologia e
Psichiatria Sociale, 17, 1: 28-30.
I.F. 2007: 2.900
11
Bellani M, Brambilla P. Social cognition, schizophrenia and brain imaging. Epidemiologia e Psichiatria Sociale. In
press.
I.F. 2007: 2.900
Bellani M, Brambilla P. The use and meaning of the continuous performance test in schizophrenia. Epidemiologia e
Psichiatria Sociale. In press.
I.F. 2007: 2.900
Burti L., Mazzi M., Koeter M., Schene A., Helm H., Puschner B., Bindman J., Leese M., Thornicroft G. & Tansella M.
An empirical method to identify patterns in the course of psychotic episodes of people with schizophrenia
International Journal of Methods in Psychiatry Research, in press.
I.F. 2007: 2.298
Cipriani A, Furukawa TA, Geddes J, Malvini L, Signoretti A, McGuire H, Churchill R, Nakagawa A, Barbui C. Does
randomised evidence support sertraline as first-line antidepressant for adults with acute major depression? A
systematic review and meta-analysis. Journal of Clinical Psychiatry, in press.
I.F. 2007: 5.060
Cipriani A. & Barbui C. Commentary: The efficacy and safety of aripiprazole as adjunctive therapy in major depressive
disorder: a multicenter, randomized, double-blind, placebo-controlled study. Evidence Based Mental Health, in
press.
Cipriani A. & Barbui C. Commentary: Augmentation of antidepressants with atypical antipsychotic medications for
treatment-resistant major depressive disorder: A meta-analysis. Evidence Based Mental Health, in press.
Cipriani A. & Barbui C. What is an intention to treat analysis? Epidemiologia e Psichiatria Sociales, in press.
I.F. 2007: 2.900
Cipriani A, Dieterich M, Barbui C. (2008). Atypical antipsychotics are effective adjuncts for treatment resistant
depression but increase discontinuation due to adverse effects. Evidence Based Mental Health, 11, 14.
Cipriani A, Nosè M, Barbui C. (2008). Allocation concealment and blinding in clinical trials. Epidemiologia e
Psichiatria Sociale, 17, 115-116.
I.F. 2007: 2.900
Del Piccolo L., Mazzi M.A., Scardoni S., Gobbi M. & Zimmermann C. A proposal to get hold of nine dimensions of
patient-centred communication: The Verona Patient-Centred Communication Rating Scale. Health Education, in
press.
Furukawa T.A., Barbui C., Cipriani A., Brambilla P. & Watanabe N. Borrowing standard deviations for a meta-analysis
when they are not reported in the original randomized trials. Journal of Clinical Epidemiology, in press
I.F. 2007: 2.565
Goss C, Moretti F, Mazzi M.A, Del Piccolo L, Rimondini M, Zimmermann C. Involving patients in decisions during
psychiatric consultations. British Journal of Psychiatry. In press.
I.F. 2007: 5.446
Lasalvia A. & Tansella M. (2008) Fighting discrimination and stigma against people with mental disorders.
Epidemiologia e Psichiatria Sociale, 17, 1-9.
I.F. 2007: 2.900
Leese M., Schene A., Koeter M., Meijer C., Bindman J., Mazzi F., Puschner B., Burti L., Becker T., Moreno M., Celani
D. & White I.R. How to use the SF-36 for patients with schizophrenia: feasibility, reliability and score
aggregation. Journal of Clinical Epidemiology, in press.
I.F. 2007: 2.565
Mazzucco S., Cipriani A., Barbui C. & Monaco S. Antipsychotic drugs and cerebrovascular events in elderly patients
with dementia: a systematic review. Mini-Reviews in Medicinal Chemistry, in press.
I.F. 2007: 3.060
Mulè S., Cipriani A. & Barbui C. Aripiprazole in addition to clozapine in partially responsive patients with
schizophrenia: a critical review of case series. Clinical Schizophrenia & Related Psychoses, in press.
Nakagawa A., Watanabe N., Omori I.M., Barbui C., Cipriani A., McGuire H., Churchill R., Furukawa T.A., on behalf
of the Multiple meta-Analyses of New Generation Antidepressants (MANGA) Study Group. Efficacy and
acceptability of milnacipran in the treatment of major depression in comparison with other antidepressants: a
systematic review and meta-analysis. CNS Drugs, in press.
I.F. 2007: 4.514
Nosè M., Tansella M., Thornicroft G., Schene A., Becker T., Veronese A., Leese M., Koeter M., Angermeyer M &
Barbui C. Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
I.F. 2007: 3.262
International Clinical Psychopharmacology , in press.
Omori I.M., Watanabe N., Nakagawa A., Akechi T., Cipriani A., Barbui C., McGuire H., Churchill R., Furukawa T.A.,
on behalf of the Multiple meta-Analyses of New Generation Antidepressants (MANGA) Study Group. Efficacy,
12
tolerability and side effect profile of fluvoxamine for major depression: meta-analysis. Journal of
Psychopharmacology, in press.
I.F. 2007: 3.782
Paccaloni M., Rimondini M., Pozzan T. & Zimmermann C. La comunicazione della diagnosi di schizofrenia. Il punto di
vista degli psichiatri raccolto attraverso il metodo dei focus group. Epidemiologia e Psichiatria Sociale, in press.
I.F. 2007: 2.900
Puschner B., Angermeyer M.C., Leese M., Thornicroft G., Schene A., Kikkert M., Burti L., Tansella M. & Becker T.
Course of adherence to medication and quality of life in people with schizophrenia. Psychiatry Research, in
press.
I.F. 2007: 2.298
Rimondini, M., Del Piccolo L., Goss, C., Mazzi, M., Paccaloni, M. & Zimmermann, C. The evaluation of a
training in patient-centred interviewing skills for psychiatric residents. Psychological Medicine, in press
I.F. 2007: 4.212
Rossi A., Amaddeo F., Sandri M., Marsilio A., Bianco M. & Tansella M. (2008). What happens to patients seen onceonly by psychiatric services? Findings from a follow-up study. Psychiatry Research 157, 53-65.
I.F. 2007: 2.298
Ruggeri M. & Tansella M. (2008). Case management or assertive community treatment: are they really alternative
approaches? Epidemiologia e Psichiatria Sociale, 17, 93-98.
I.F. 2007: 2.900
Tavano A, Sponda S, Fabbro F, Perlini C, Rambaldelli G, Ferro A, Cerruti S, Tansella M, Brambilla P. (2008) Specific
linguistic and pragmatic deficits in Italian patients with schizophrenia. Schizophrenia Research. 102, 53-62.
I.F. 2007: 4.240
Thornicroft G., Tansella M. & Law A. (2008) Steps, challenges & lessons in improving community mental health care.
World Psychiatry 7, 87-92.
Watanabe N., Omori I.M., Nakagawa A., Cipriani A., Barbui C., McGuire H., Churchill R. & Furukawa T.A.
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression:
Systematic review and meta-analysis. Journal of Clinical Psychiatry, in press.
I.F. 2007: 5.060
B) PAPERS AND REVIEWS PUBLISHED IN INTERNATIONAL BOOKS AND MONOGRAPHS
Amaddeo F., Becker T., Fioritti A., Burti L. & Tansella M. (2007). Reforms in community care: the balance between
hospital and community-based mental health care. In Mental Health Policy and Practice Across Europe. The
Future Direction of Mental Health Care (ed. M. Knapp, D. McDaid, E. Mossialos and G. Thornicroft), pp. 235249. Open University Press: London.
Barbui C., Cipriani A. & Tansella M. (2007). Beneficial and adverse effects of antidepressants on suicide mortality in
individuals with major depression. In Suicide in Psychiatric Disorders (ed. R. Tatarelli, M. Pompili and P.
Girardi), pp. 19-36. Nova Science Publishers Inc.: New York.
in press
Barbui C. & Tansella M. Identification and management of mental distress in primary care: Focus on depression. In
Psiquiatrìa en Atenciòn Primaria, 2nd Ed. (ed. J.L. Vazquez-Barquero), Aula Medica: Madrid, in press.
Brambilla P., Balestrieri M, Soares J.C. Neuroimaging studies in generalized anxiety disorder. In: Understanding
Anxiety. ed. G. Kinrys and P. Renshaw. In press.
Slade M., Thornicroft G. & Tansella M. Service needs of individuals and populations. In New Oxford Textbook of
Psychiatry, 2nd Ed. (ed. M.G. Gelder, J.J. Lopez Ibor, N. Andreasen & J. Geddes). Oxford University Press:
Oxford, in press.
Tansella M., Thornicroft G. & Susser E. Community psychiatry and service delivery models. In Essentials of Psychiatry
(ed. R. Murray, K.S. Kendler, P. McGuffin, S. Wessely and D. Castle). Cambridge University Press: Cambridge,
in press.
Tansella M. & Thornicroft G. Evaluation of mental health services. In New Oxford Textbook of Psychiatry, 2nd Ed. (ed.
M.G. Gelder, J.J. Lopez Ibor, N. Andreasen and J. Geddes. Oxford University Press: Oxford, in press.
13
C) PAPERS PUBLISHED IN ITALIAN JOURNALS
Amaddeo F. & Grigoletti L. (2007). Sistemi informativi in psichiatria. Informazione Epidemiologia Salute, 4-6.
Barbui C. (2007). Appropriatezza prescrittiva degli antipsicotici negli anziani. L'
esperienza statunitense. CARE 6, 2021.
Bellantuono C., Migliarese G., Maggioni F. & Imperadore G. (2007). L'
impiego dei farmaci antidepressivi nel
puerperio. Recenti Progressi in Medicina 98, 29-42.
De Girolamo G. & Tansella M. (2007) Prefazione. Epidemiologia psichiatrica: Nuove direzioni. Noos,No. 48, 127-128.
Del Piccolo L. (2007). La comunicazione di tumore al paziente e ai familiari: linee guida. Recenti Progressi in
Medicina 98, N. 5, 271-278.
Fontanesi S, Goss C, Rimondini M. (2007). Come coinvolgere il paziente nelle decisioni che riguardano la salute.
Strategie comunicative. Recenti Progressi in Medicina, 98, 611-18
Grigoletti L., Rossi A., Zulian G. & Amaddeo F. (2007). Registri psichiatrici e geografia della salute mentale. Nóo –
Aggiornamenti in psichiatria, 13, 177-190.
Lasalvia A. & Ruggeri M. (2007). Valutare gli esiti dell'
assistenza nella routine dei servizi di salute mentale per
migliorare la pratica clinica. L'
esperienza del Progetto Outcome di Verona-Sud. Psichiatria e Psicoterapia 26,
191-201.
Lasalvia A. & Ruggeri M. (2007). Diagnosi cliniche e bisogni dei pazienti: personalizzare le cure per un nuovo
approccio alla salute mentale. Salute e Società 3, 251- 258.
Nosè M, Veronese A, Cipriani A, Barbui C. (2007). La ricerca in farmacoepidemiologia: dalla logica descrittiva
all’approccio “epidemiologico-sperimentale”. Noos, 3, 129-140.
Pellegrini N. & Ruggeri M. (2007). L'
efficacia delle medicine alternative e complementari nella terapia dei disturbi
psichici: una revisione sistematica della letteratura. Psichiatria di Comunità 6, 152-180.
Pontarollo F., Cipriani A., Signoretti A., Girardi S. & Barbui C. (2007). Profilo di efficacia e tollerabilità
dell’escitalopram rispetto agli altri farmaci antidepressivi nel trattamento acuto della depressione maggiore:
revisione sistematica e meta-analisi. Minerva Psichiatrica 48, 129-141.
in press
Esposito E. & Barbui C. Strategie per il depresso lieve e per quello irriducibile. Occhio Clinico, in press.
D) PAPERS PUBLISHED IN ITALIAN BOOKS AND MONOGRAPHS
Amaddeo F. & Grigoletti L. (2007). Disuguaglianze e salute mentale. In Lavori, Disuguaglianze e Protezione Sociale
(ed. G. Gosetti) pp.176-195. Franco Angeli: Milano.
Balestrieri M., Panseri A. & Burti L: (2007). Il dipartimento di salute mentale e la psichiatria di comunità. In Manuale
di Psichiatria (a cura di A. Siracusano, M. Balestrieri, C. Bellantuono, D. Berardi, M. di Giannantonio, M.
Rigatelli, R. A. Zoccali, I. A. Rubino e A. Troisi) pp. . Il Pensiero Scientifico Editore: Roma
Bellantuono C. (2007). Psicofarmaci. In Psiche. Dizionario Sorico di Psicologia, Psichiatria, Psicoanalisi,
Neuroscienze (ed. F. Barale, M. Bertani, V. Gallese, S. Mistura e A. Zaperini), pp. 865-869. Einaudi: Torino.
Bellantuono C. & Imperadore G. (2007). Psicofarmacoterapia. In Trattato di Psichiatria (ed. A. Siracusano, M.
Balestrieri, C. Bellantuono, D. Berardi e M. Rigatetelli), pp. 686-729. Il Pensiero Scientifico: Roma.
Cipriani A. & Barbui C. (2007). Disturbi bipolari. In Enciclopedia Medica Italiana (Direttore Scientifico: L. Vella), pp.
436-444. UTET Scienze Mediche: Torino.
14
Goss C., Rimondini M. & Zimmermann C. (2007). Come mettere a confronto le evidenze con i valori e le preferenze
del malato. In Introduzione alla Evidence Based Medicine, Corso online sul sito web
www.ariadne.bz.it/corsi/ebm.asp. Il Pensiero Scientifico Editore: Roma.
Tansella M. (2007). La scoperta del “continente inesplorato” dei disturbi mentali nella medicina generale ed i suoi
effetti sullo stile di lavoro degli psichiatri nella comunità. Introduzione a I Pazienti con Disturbi Psichiatrici
nell’Ambulatorio del Medico di Medicina Generale, pp. IX-XXIII (ed. F. Asioli e D. Berardi). Il Pensiero
Scientifico Editore: Roma.
in press
Amaddeo F. (2008). I costi dei disturbi dell’umore. In: Trattato Italiano di Psichiatria, terza edizione. Masson Editore,
Milano, in press.
Lasalvia A. & Ruggeri M. La valutazione degli esiti degli interventi e dei trattamenti in una prospettiva epidemiologica.
In Epidemiologia Psichiatrica: Nuove Direzioni” (ed. G. de Girolamo e M. Tansella). Noos, Numero
monografico, in press.
Lasalvia A. & Ruggeri M. La valutazione degli esiti in salute mentale: problemi ed obiettivi. In La Comunità
Terapeutica. Istruzione per l’Uso, 2 ed. (ed. F. Asioli e M. Purpura). Biblink Omnia: Roma, in press.
Tansella M. La valutazione scientifica dei trattamenti in medicina ed il ritardo della psichiatria. In Filosofia della
Medicina (ed. P. Giaretta e A. Moretto). Il Mulino: Bologna, in press.
Tansella M. (2008), La formazione degli operatori della salute mentale e l’ educazione alla salute. In L’Educazione alla
Salute. Rapporto Sanità 2008 (a cura di G.F. Genuini, P. Rizzino, M. Trabucchi e F. Vanara), pp. 125-136.
Società Editrice Il Mulino: Bologna.
E) INTERNATIONAL BOOKS
Brambilla P. & Tansella M. (ed.) (2007). Neuroimaging Studies and Schizophrenia The Road Travelled, The Road
Ahead. Special Issue of International Review of Psychiatry, Volume 19, Issue No. 4, August 2007, pp. 313-468.
Routledge: London.
Lasalvia A. & Ruggeri M. (2007) (ed.). Multidimensional Outcomes in 'Real World' Mental Health Services. Follow-up
Findings from the South-Verona Outcome Project. Acta Psychiatrica Scandinavica, Supplementum 437, Vol.
116, pp. 1-77. Blackwell Munksgaard: Frederiksberg.
in press
Thornicroft G. & Tansella M. Better Mental Health Care. Cambridge University Press, Cambridge, in press.
F) NATIONAL BOOKS
de Girolamo G. & Tansella M. (ed.) (2008) Epidemiologia Psichiatrica. Nuove Direzioni. Noos, Numero Monografico.
Il Pensiero Scientifico Editore: Roma.
15